Background Sex and gender have increasingly been recognized as significant risk factors
for many diseases, including dermatological conditions. Historically, sex and gender have …

Aims Infliximab is a tumour necrosis factor‐alpha inhibitor that is used to treat children with
refractory Kawasaki disease (KD). Our purpose was to evaluate the safety and impact of …

Background The risk of cardiovascular events after Kawasaki disease (KD) remains
uncertain. Our objective was to determine the risk of cardiovascular events and mortality …

Kawasaki disease (KD) is a hyperinflammatory syndrome manifesting as an acute systemic
vasculitis characterized by fever, nonsuppurative conjunctival injection, rash, oral mucositis …

Background We aimed to explore simple and effective clinical parameters or combinations
to predict coronary artery dilation and aneurysm formation in pediatric patients with …

Introduction The aim of this national prospective surveillance study was to compare the
clinical presentation, laboratory findings, treatment, and coronary artery outcome in patients …

An Update on Kawasaki Disease | Current Rheumatology Reports Skip to main content
Springer Nature Link Account Menu Find a journal Publish with us Track your research …

Abstract Background Kawasaki Disease (KD) is the leading cause of acquired heart disease
in children in developed countries with a variable incidence worldwide. Previous studies …

Introduction Kawasaki disease (KD) is an acute idiopathic systemic vasculitis with a self-
limiting course that predominantly affects children under 5 years old, particularly in the East …

Kawasaki disease (KD) primarily affects young children and can lead to coronary artery
lesions. Intravenous immunoglobulin (IVIG) treatment is essential; however, it may fail in 10 …